Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01390194 · ClinicalTrials.gov registry record
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 25
- Enrollment target
NCT01390194: Completed study, sponsored by University of Nebraska.
NCT01390194 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01390194 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this study to assess the image quality of the rapid magnetic resonance imaging (MRI) compared to the standard MRI.
Primary Outcome
Two MRI exams will be evaluated by two radiologists based on a number of items.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-07-01 |
| Est. Completion | 2015-06-01 |
What the finished NCT01390194 record still lists
NCT01390194 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01390194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01390194 about?
NCT01390194 is a clinical study titled "Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma". The purpose of this study to assess the image quality of the rapid magnetic resonance imaging (MRI) compared to the standard MRI.
What is the current status of trial NCT01390194?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2011-07-01. Estimated completion is 2015-06-01.
Who is sponsoring clinical trial NCT01390194?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI